Form 4 for URGN UroGen Pharma Ltd.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001437749-23-002338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-02 | 2023-01-31 | URGN | Smith Jason Drew | GC | S - Sale+OE | $10.12 | -1,636 | 13.9K | -11% | -$16.6K |
| DM | 2023-02-02 | 2023-01-31 | URGN | Smith Jason Drew | GC | M - OptEx | — | +3,333 | 13.0K | +34% | — |
| DM | 2023-02-02 | 2023-01-31 | URGN | Smith Jason Drew | GC | A - Grant | $0.00 | +60.0K | 40.0K | New | $0 |
| DM | 2023-02-02 | 2023-01-31 | URGN | Smith Jason Drew | GC | M - OptEx | $0.00 | -3,333 | 834 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-01-31 | S | D | 409 | $10.12 | 12,600 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 2 | Common | Ordinary Shares | 2023-01-31 | S | D | 1,227 | $10.12 | 13,873 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 3 | Common | Ordinary Shares | 2023-01-31 | M | A | 2,500 | — | 15,100 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 4 | Common | Ordinary Shares | 2023-01-31 | M | A | 833 | — | 13,009 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 5 | Derivative | Restricted Stock Units | 2023-01-31 | A | A | 20,000 | $0.00 | 20,000 | D | — · — to — | 20,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F5) 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. |
| 6 | Derivative | Restricted Stock Units | 2023-01-31 | M | D | 2,500 | $0.00 | 5,000 | D | — · — to — | 2,500 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F4) The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. |
| 7 | Derivative | Restricted Stock Units | 2023-01-31 | M | D | 833 | $0.00 | 834 | D | — · — to — | 833 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-01-31 | A | A | 40,000 | $0.00 | 40,000 | D | $10.39 · — to 2033-01-31 | 40,000 Ordinary Shares | (F6) 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. |